UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 512

Sortiert nach

The Evolving Role of Monoclonal Antibodies in Colorectal Cancer: Early Presumptions and Impact on Clinical Trial Development

The oncologist (Dayton, Ohio), 2010-01, Vol.15 (1), p.73-84

Eng, Cathy

2010

Link zum Volltext

Verfügbarkeit prüfen

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group

The oncologist (Dayton, Ohio), 2020-06, Vol.25 (6), p.e936-e945

2020

Link zum Volltext

Verfügbarkeit prüfen

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (28), p.3240-3261

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiemetics: ASCO Guideline Update

Journal of clinical oncology, 2020-08, Vol.38 (24), p.2782-2797

2020

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

Clinical cancer research, 2019-10, Vol.25 (19), p.5852-5858

2019

Link zum Volltext

Verfügbarkeit prüfen

Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes

Clinical cancer research, 2018-03, Vol.24 (5), p.1062-1072

2018

Link zum Volltext

Verfügbarkeit prüfen

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3677-3683

2009

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

Journal of clinical oncology, 2012-05, Vol.30 (15), p.1770-1776

2012

Link zum Volltext

Verfügbarkeit prüfen

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1083-1090

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized controlled trial of neurofeedback on chemotherapy‐induced peripheral neuropathy: A pilot study

Cancer, 2017-06, Vol.123 (11), p.1989-1997

2017

Link zum Volltext

Verfügbarkeit prüfen

BRAF Mutation in Colorectal Cancer: An Enigmatic Target

Journal of clinical oncology, 2021-02, Vol.39 (4), p.259-261

Eng, Cathy

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.824-830

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Journal of clinical oncology, 2010-01, Vol.28 (3), p.453-459

2010

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy for Colon Cancer

Cancers, 2020-09, Vol.12 (9), p.2368

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2631-2638

2017

Link zum Volltext

Verfügbarkeit prüfen

Global and targeted serum metabolic profiling of colorectal cancer progression

Cancer, 2017-10, Vol.123 (20), p.4066-4074

2017

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal

Molecular cancer research, 2017-11, Vol.15 (11), p.1542-1550

2017

Link zum Volltext

Verfügbarkeit prüfen

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up

Annals of surgical oncology, 2017-01, Vol.24 (1), p.187-193

2017

Link zum Volltext

Verfügbarkeit prüfen

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2311-2319

2008

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

Journal of clinical oncology, 2006-05, Vol.24 (13), p.2065-2072

2006

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer

Journal of clinical oncology, 2010-01, Vol.28 (3), p.493-508

2010

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5344-5351

2008

Link zum Volltext

Verfügbarkeit prüfen

The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer

PloS one, 2013-10, Vol.8 (10), p.e77117-e77117

2013

Link zum Volltext

Verfügbarkeit prüfen

Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer

CA: a cancer journal for clinicians, 2023-09, Vol.73 (5), p.516-523

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 512

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(445)
Mit Volltextzugriff
(480)

Publikationsform

Sprache

Englisch
(512)
Japanisch
(47)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(268)
Life Sciences & Biomedicine
(263)
Oncology
(223)
Humans
(218)
Female
(128)
Male
(127)
Middle Aged
(118)
Aged
(97)
Adult
(87)
Colorectal Cancer
(72)
Tumors
(59)
Cancer
(56)
Chemotherapy
(56)
Colorectal Neoplasms - Pathology
(51)
Colorectal Neoplasms - Drug Therapy
(47)
Treatment Outcome
(43)
Aged, 80 And Over
(42)
Biological And Medical Sciences
(40)
Retrospective Studies
(39)
Medical Sciences
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Evolving Role of Monoclonal Antibodies in Colorectal Cancer: Early Presumptions and Impact on Clinical Trial Development

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Antiemetics: ASCO Guideline Update

Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

Randomized controlled trial of neurofeedback on chemotherapy‐induced peripheral neuropathy: A pilot study

BRAF Mutation in Colorectal Cancer: An Enigmatic Target

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Neoadjuvant Chemotherapy for Colon Cancer

Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer

Global and targeted serum metabolic profiling of colorectal cancer progression

Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer

Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer

Suchergebnisse filtern